1021175-71-2 Usage
General Description
2-(2-Cyano-vinylaMino)-Malonicaciddiethylester is a chemical compound with the molecular formula C9H11N3O4. It is an ester derivative of malonic acid and contains a cyano group and an aminovinyl group. 2-(2-Cyano-vinylaMino)-Malonicaciddiethylester is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals, agrochemicals, and materials. It has potential applications in medicinal chemistry due to its ability to act as a precursor for the synthesis of biologically active compounds. Additionally, it has been identified as a potential inhibitor of certain enzymes, making it a target for drug development and therapeutic research. Overall, 2-(2-Cyano-vinylaMino)-Malonicaciddiethylester is a versatile chemical compound with potential applications in various fields of science and technology.
Check Digit Verification of cas no
The CAS Registry Mumber 1021175-71-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,1,1,7 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1021175-71:
(9*1)+(8*0)+(7*2)+(6*1)+(5*1)+(4*7)+(3*5)+(2*7)+(1*1)=92
92 % 10 = 2
So 1021175-71-2 is a valid CAS Registry Number.
1021175-71-2Relevant articles and documents
Improved syntheses of 3H,5H-pyrrolo[3,2-d]pyrimidines
Furneaux, Richard H.,Tyler, Peter C.
, p. 8411 - 8412 (1999)
-
PROCESS FOR THE PREPARATION OF VERDIPERSTAT
-
Paragraph 0043; 0045-0046, (2021/11/13)
An improved process for preparing verdiperstat is disclosed. The process includes the steps of reacting a compound having formula or a salt thereof, wherein R is the same or different and is each independently a C1-C5 alkyl with 3-(dimethylamino)acrylonitrile to obtain a compound having formula; and converting the compound having formula to verdiperstat.
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Page/Page column 128, (2012/08/27)
Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
